Sarah Jessica Parker Says Neigh to EpiPen

Sarah Jessica Parker has cut ties with EpiPen even though they make the Epinephrine emergency injector she slams into her son’s chest plate any time he even sees a TV ad for peanut butter. Also, they hired her to mention she loved it.

The price of the EpiPen from Mylan pharmaceutical was raised substantially earlier this year. Parker and her husband are worth about $150 million so didn’t really notice the couple hundred dollar bump until a stink was made on social media from individuals concerned they couldn’t afford the allergic reaction antidote for their own kids.

I’m left disappointed, saddened and deeply concerned by Mylan’s actions. I do not condone this decision and I have ended my relationship with Mylan as a direct result of it.

As a result, Parker will now have her assistant purchase the same drug for the same jacked up price from a competitor. Nobody wants to go to heaven on a bad hazelnut reaction.

There is no transparency on the actual costs of goods and services in healthcare so most everything is rigged or finagled to maximize payout against insurance company payments and government coverage. Poor people don’t pay for pharmaceuticals. Rich people pay out of pocket and don’t notice. Everybody in the middle has no ideas what it costs. Just cross your fingers it’s covered under your job plan when you go to CVS. This is no way to save children affected by ailments heavily centered in the homes of white celebrities in New York and Los Angeles.